Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy

Kathrin Tyryshkin, PhD, Yi D Li, MD, David Good, MD, Lois E. Shepherd, MD, Tara Baetz, MD FRCPC, Michael J. Rauh, MD PhD, David P. LeBrun, MD

Blood (2016) 128 (22): 3037.

https://doi.org/10.1182/blood.V128.22.3037.3037

Published: 2016

Journal Articles

Identification and Characterization By ChIP-Seq Of Genomic Sites Bound By E2A-PBX1 In Acute Lymphoblastic Leukemia Demonstrates Associations With p300 Recruitment, Transcriptionally Active Chromatin and Abundant Transcription

Kyster Nanan, David P LeBrun, MD

Blood (2013) 122 (21): 2501.

https://doi.org/10.1182/blood.V122.21.2501.2501

Published: 2013

Journal Articles

Developing a Multidimensional Prognostic Test for Follicular Lymphoma.

Cheryl J. Foster, BSc, Tara Baetz, MD, Roland Somogyi, PhD, Larry D. Greller, PhD, Roger Sidhu, MD, Patricia Farmer, MD, Harriet E. Feilotter, PhD, David P. LeBrun, MD

Blood (2007) 110 (11): 2610.

https://doi.org/10.1182/blood.V110.11.2610.2610

Published: 2007

Journal Articles

Identification of Combined Clinical and Biomarker Prognostic Factors in Follicular Lymphoma.

Cheryl J. Foster, BSc, Patricia L. Farmer, MD, Tara Baetz, MD, Julia Brettschneider, PhD, Harriet E. Feilotter, PhD, David P. LeBrun, MD

Blood (2006) 108 (11): 4603.

https://doi.org/10.1182/blood.V108.11.4603.4603

Published: 2006

Journal Articles

Use of a Tissue Microarray To Assess the Accuracy of Lymphoma Classification by Needle Biopsy.

Patricia L. Farmer, MD, Shakeel U. Virk, B.Sc, Bruce F. Burns, MD, David P. LeBrun, MD

Blood (2005) 106 (11): 1006.

https://doi.org/10.1182/blood.V106.11.1006.1006

Published: 2005

NARROW

Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy

Identification and Characterization By ChIP-Seq Of Genomic Sites Bound By E2A-PBX1 In Acute Lymphoblastic Leukemia Demonstrates Associations With p300 Recruitment, Transcriptionally Active Chromatin and Abundant Transcription

Developing a Multidimensional Prognostic Test for Follicular Lymphoma.

Identification of Combined Clinical and Biomarker Prognostic Factors in Follicular Lymphoma.

Use of a Tissue Microarray To Assess the Accuracy of Lymphoma Classification by Needle Biopsy.

Email alerts

ASH Publications

American Society of Hematology

Differential Expression of TCF3 Target Genes Defines Subclasses of Diffuse Large B-Cell Lymphoma with Striking Differences in Clinical Outcome Following R-CHOP Therapy

Identification and Characterization By ChIP-Seq Of Genomic Sites Bound By E2A-PBX1 In Acute Lymphoblastic Leukemia Demonstrates Associations With p300 Recruitment, Transcriptionally Active Chromatin and Abundant Transcription

Developing a Multidimensional Prognostic Test for Follicular Lymphoma.

Identification of Combined Clinical and Biomarker Prognostic Factors in Follicular Lymphoma.

Use of a Tissue Microarray To Assess the Accuracy of Lymphoma Classification by Needle Biopsy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only